These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

241 related items for PubMed ID: 15957505

  • 1. 25-Hydroxyvitamin D levels in serum at the onset of multiple sclerosis.
    Soilu-Hänninen M, Airas L, Mononen I, Heikkilä A, Viljanen M, Hänninen A.
    Mult Scler; 2005 Jun; 11(3):266-71. PubMed ID: 15957505
    [Abstract] [Full Text] [Related]

  • 2. A longitudinal study of serum 25-hydroxyvitamin D and intact parathyroid hormone levels indicate the importance of vitamin D and calcium homeostasis regulation in multiple sclerosis.
    Soilu-Hänninen M, Laaksonen M, Laitinen I, Erälinna JP, Lilius EM, Mononen I.
    J Neurol Neurosurg Psychiatry; 2008 Feb; 79(2):152-7. PubMed ID: 17578859
    [Abstract] [Full Text] [Related]

  • 3. Association of seasonal serum 25-hydroxyvitamin D levels with disability and relapses in relapsing-remitting multiple sclerosis.
    Brola W, Sobolewski P, Szczuchniak W, Góral A, Fudala M, Przybylski W, Opara J.
    Eur J Clin Nutr; 2016 Sep; 70(9):995-9. PubMed ID: 27026420
    [Abstract] [Full Text] [Related]

  • 4. Hypovitaminosis D association with disease activity in relapsing remitting multiple sclerosis in Brazil.
    Becker J, Callegaro D, Lana-Peixoto MA, Talim N, Vidaletti T, de Paula Corrêa M, Gomes I.
    J Neurol Sci; 2016 Apr 15; 363():236-9. PubMed ID: 27000256
    [Abstract] [Full Text] [Related]

  • 5. Higher 25-hydroxyvitamin D is associated with lower relapse risk in multiple sclerosis.
    Simpson S, Taylor B, Blizzard L, Ponsonby AL, Pittas F, Tremlett H, Dwyer T, Gies P, van der Mei I.
    Ann Neurol; 2010 Aug 15; 68(2):193-203. PubMed ID: 20695012
    [Abstract] [Full Text] [Related]

  • 6. Vitamin D supplementation reduces relapse rate in relapsing-remitting multiple sclerosis patients treated with natalizumab.
    Laursen JH, Søndergaard HB, Sørensen PS, Sellebjerg F, Oturai AB.
    Mult Scler Relat Disord; 2016 Nov 15; 10():169-173. PubMed ID: 27919484
    [Abstract] [Full Text] [Related]

  • 7. Association of vitamin D metabolite levels with relapse rate and disability in multiple sclerosis.
    Smolders J, Menheere P, Kessels A, Damoiseaux J, Hupperts R.
    Mult Scler; 2008 Nov 15; 14(9):1220-4. PubMed ID: 18653736
    [Abstract] [Full Text] [Related]

  • 8. Association of vitamin D and multiple sclerosis in India.
    Pandit L, Ramagopalan SV, Malli C, D'Cunha A, Kunder R, Shetty R.
    Mult Scler; 2013 Oct 15; 19(12):1592-6. PubMed ID: 23519972
    [Abstract] [Full Text] [Related]

  • 9. Seasonal variations of 25-OH vitamin D serum levels are associated with clinical disease activity in multiple sclerosis patients.
    Hartl C, Obermeier V, Gerdes LA, Brügel M, von Kries R, Kümpfel T.
    J Neurol Sci; 2017 Apr 15; 375():160-164. PubMed ID: 28320120
    [Abstract] [Full Text] [Related]

  • 10. A low vitamin D status at diagnosis is associated with an early conversion to secondary progressive multiple sclerosis.
    Muris AH, Rolf L, Broen K, Hupperts R, Damoiseaux J, Smolders J.
    J Steroid Biochem Mol Biol; 2016 Nov 15; 164():254-257. PubMed ID: 26598277
    [Abstract] [Full Text] [Related]

  • 11. Basal vitamin D levels and disease activity in multiple sclerosis patients treated with fingolimod.
    Ferre' L, Clarelli F, Sferruzza G, Rocca MA, Mascia E, Radaelli M, Sangalli F, Dalla Costa G, Moiola L, Aboulwafa M, Martinelli Boneschi F, Comi G, Filippi M, Martinelli V, Esposito F.
    Neurol Sci; 2018 Aug 15; 39(8):1467-1470. PubMed ID: 29756179
    [Abstract] [Full Text] [Related]

  • 12. Association of vitamin D status and clinical and radiological outcomes in a treated MS population in Poland.
    Wawrzyniak S, Mikołajewska E, Kuczko-Piekarska E, Niezgodzińska-Maciejek A, Goch A.
    Brain Behav; 2017 Feb 15; 7(2):e00609. PubMed ID: 28239520
    [Abstract] [Full Text] [Related]

  • 13. Circulating vitamin D binding protein levels are not associated with relapses or with vitamin D status in multiple sclerosis.
    Smolders J, Peelen E, Thewissen M, Menheere P, Damoiseaux J, Hupperts R.
    Mult Scler; 2014 Apr 15; 20(4):433-7. PubMed ID: 23959712
    [Abstract] [Full Text] [Related]

  • 14. Vitamin D supplementation and monitoring in multiple sclerosis: who, when and wherefore.
    Holmøy T, Torkildsen Ø, Myhr KM, Løken-Amsrud KI.
    Acta Neurol Scand Suppl; 2012 Apr 15; (195):63-9. PubMed ID: 23278659
    [Abstract] [Full Text] [Related]

  • 15. Interdependence and contributions of sun exposure and vitamin D to MRI measures in multiple sclerosis.
    Zivadinov R, Treu CN, Weinstock-Guttman B, Turner C, Bergsland N, O'Connor K, Dwyer MG, Carl E, Ramasamy DP, Qu J, Ramanathan M.
    J Neurol Neurosurg Psychiatry; 2013 Oct 15; 84(10):1075-81. PubMed ID: 23385850
    [Abstract] [Full Text] [Related]

  • 16. Vitamin D related genetic polymorphisms affect serological response to high-dose vitamin D supplementation in multiple sclerosis.
    Mimpen M, Rolf L, Poelmans G, van den Ouweland J, Hupperts R, Damoiseaux J, Smolders J.
    PLoS One; 2021 Oct 15; 16(12):e0261097. PubMed ID: 34855907
    [Abstract] [Full Text] [Related]

  • 17. Higher levels of 25-hydroxyvitamin D are associated with a lower incidence of multiple sclerosis only in women.
    Kragt J, van Amerongen B, Killestein J, Dijkstra C, Uitdehaag B, Polman Ch, Lips P.
    Mult Scler; 2009 Jan 15; 15(1):9-15. PubMed ID: 18701572
    [Abstract] [Full Text] [Related]

  • 18. Multiple sclerosis patients have a diminished serologic response to vitamin D supplementation compared to healthy controls.
    Bhargava P, Steele SU, Waubant E, Revirajan NR, Marcus J, Dembele M, Cassard SD, Hollis BW, Crainiceanu C, Mowry EM.
    Mult Scler; 2016 May 15; 22(6):753-60. PubMed ID: 26286698
    [Abstract] [Full Text] [Related]

  • 19. Vitamin D levels in people with multiple sclerosis and community controls in Tasmania, Australia.
    van der Mei IA, Ponsonby AL, Dwyer T, Blizzard L, Taylor BV, Kilpatrick T, Butzkueven H, McMichael AJ.
    J Neurol; 2007 May 15; 254(5):581-90. PubMed ID: 17426912
    [Abstract] [Full Text] [Related]

  • 20. Lower 25-Hydroxyvitamin D Is Associated with Higher Relapse Risk in Patients with Relapsing-Remitting Multiple Sclerosis.
    Wang C, Zeng Z, Wang B, Guo S.
    J Nutr Health Aging; 2018 May 15; 22(1):38-43. PubMed ID: 29300420
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.